First Affiliated Hospital of Soochow University
First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Assess the Efficacy and Safety of Furmonertinib Versus Placebo, in Patients With Epidermal Growth Factor Receptor Mutation Positive Stage II-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2026-08-13 | NCT04853342 | |
| Evaluation of the Safety and Efficacy of Human CI-135 (FLT3) Targeted CAR-T Cells Injection for Subjects with Relapsed/Refractory Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Early phase 1 | 2025-01-07 | NCT06760260 | |
| A Study of Olverembatinib Combined With Blinatumomab in the Treatment of Ph+ ALL | Philadelphia-Positive ALL | Not yet recruiting | Phase 2 | 2023-07-05 | NCT05931757 | |
| Olverembatinib for FGFR1-rearranged Neoplasms | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, acute leukemia, bone marrow disorder, hematologic disorder, myeloproliferative neoplasm | Recruiting | Phase 2 | 2022-08-30 | NCT05521204 | |
| AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 / Phase 3 | 2022-08-19 | NCT05404906 |